177 related articles for article (PubMed ID: 35904184)
1. The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment.
Fiorillo C; Capodivento G; Geroldi A; Tozza S; Moroni I; Mohassel P; Cataldi M; Campana C; Morando S; Panicucci C; Pedemonte M; Brolatti N; Siliquini S; Traverso M; Baratto S; Debellis D; Magri S; Prada V; Bellone E; Salpietro V; Donkervoort S; Gable K; Gupta SD; Dunn TM; Bönnemann CG; Taroni F; Bruno C; Schenone A; Mandich P; Nobbio L; Nolano M
Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12842. PubMed ID: 35904184
[TBL] [Abstract][Full Text] [Related]
2. Recurrent de novo
Syeda SB; Lone MA; Mohassel P; Donkervoort S; Munot P; França MC; Galarza-Brito JE; Eckenweiler M; Asamoah A; Gable K; Majumdar A; Schumann A; Gupta SD; Lakhotia A; Shieh PB; Foley AR; Jackson KE; Chao KR; Winder TL; Catapano F; Feng L; Kirschner J; Muntoni F; Dunn TM; Hornemann T; Bönnemann CG
J Neurol Neurosurg Psychiatry; 2024 Jan; 95(2):103-113. PubMed ID: 38041679
[TBL] [Abstract][Full Text] [Related]
3. Expanding the spectrum of SPTLC1-related disorders beyond hereditary sensory and autonomic neuropathies: A novel case of the distinct "S331 syndrome".
Rossi F; Bruno G; Fratta M; Colavito D; Casertano S; Sampaolo S; Oliva M; Puoti G
J Peripher Nerv Syst; 2020 Sep; 25(3):308-311. PubMed ID: 32470188
[TBL] [Abstract][Full Text] [Related]
4. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
Lone MA; Aaltonen MJ; Zidell A; Pedro HF; Morales Saute JA; Mathew S; Mohassel P; Bönnemann CG; Shoubridge EA; Hornemann T
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900868
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of SPTLC1-related disorders: a novel case of 'Ser331 syndrome' that expand the phenotype of hereditary sensory and autonomic neuropathy type 1A and motor neuron diseases.
Lorenzoni PJ; Bayer DL; Ducci RD; Fustes OJH; do Vale Pascoal Rodrigues PR; Werneck LC; Kay CSK; Scola RH
Neurol Sci; 2023 Jul; 44(7):2551-2554. PubMed ID: 36964315
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
Rotthier A; Penno A; Rautenstrauss B; Auer-Grumbach M; Stettner GM; Asselbergh B; Van Hoof K; Sticht H; Lévy N; Timmerman V; Hornemann T; Janssens K
Hum Mutat; 2011 Jun; 32(6):E2211-25. PubMed ID: 21618344
[TBL] [Abstract][Full Text] [Related]
7. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
Garofalo K; Penno A; Schmidt BP; Lee HJ; Frosch MP; von Eckardstein A; Brown RH; Hornemann T; Eichler FS
J Clin Invest; 2011 Dec; 121(12):4735-45. PubMed ID: 22045570
[TBL] [Abstract][Full Text] [Related]
8. The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy.
Suriyanarayanan S; Auranen M; Toppila J; Paetau A; Shcherbii M; Palin E; Wei Y; Lohioja T; Schlotter-Weigel B; Schön U; Abicht A; Rautenstrauss B; Tyynismaa H; Walter MC; Hornemann T; Ylikallio E
Neuromolecular Med; 2016 Mar; 18(1):81-90. PubMed ID: 26573920
[TBL] [Abstract][Full Text] [Related]
9. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
[TBL] [Abstract][Full Text] [Related]
10. Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype.
Auer-Grumbach M; Bode H; Pieber TR; Schabhüttl M; Fischer D; Seidl R; Graf E; Wieland T; Schuh R; Vacariu G; Grill F; Timmerman V; Strom TM; Hornemann T
Eur J Med Genet; 2013 May; 56(5):266-9. PubMed ID: 23454272
[TBL] [Abstract][Full Text] [Related]
11. Functional and Molecular Characterization of New
Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
[TBL] [Abstract][Full Text] [Related]
12. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
Hines TJ; Tadenev ALD; Lone MA; Hatton CL; Bagasrawala I; Stum MG; Miers KE; Hornemann T; Burgess RW
J Anat; 2022 Nov; 241(5):1169-1185. PubMed ID: 34875719
[TBL] [Abstract][Full Text] [Related]
13. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
[TBL] [Abstract][Full Text] [Related]
14. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
Penno A; Reilly MM; Houlden H; Laurá M; Rentsch K; Niederkofler V; Stoeckli ET; Nicholson G; Eichler F; Brown RH; von Eckardstein A; Hornemann T
J Biol Chem; 2010 Apr; 285(15):11178-87. PubMed ID: 20097765
[TBL] [Abstract][Full Text] [Related]
15. Early-onset severe hereditary sensory and autonomic neuropathy type 1 with S331F SPTLC1 mutation.
Suh BC; Hong YB; Nakhro K; Nam SH; Chung KW; Choi BO
Mol Med Rep; 2014 Feb; 9(2):481-6. PubMed ID: 24247255
[TBL] [Abstract][Full Text] [Related]
16. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
[TBL] [Abstract][Full Text] [Related]
17. A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.
Hornemann T; Penno A; Richard S; Nicholson G; van Dijk FS; Rotthier A; Timmerman V; von Eckardstein A
Neurogenetics; 2009 Apr; 10(2):135-43. PubMed ID: 19132419
[TBL] [Abstract][Full Text] [Related]
18. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.
Mohassel P; Donkervoort S; Lone MA; Nalls M; Gable K; Gupta SD; Foley AR; Hu Y; Saute JAM; Moreira AL; Kok F; Introna A; Logroscino G; Grunseich C; Nickolls AR; Pourshafie N; Neuhaus SB; Saade D; Gangfuß A; Kölbel H; Piccus Z; Le Pichon CE; Fiorillo C; Ly CV; Töpf A; Brady L; Specht S; Zidell A; Pedro H; Mittelmann E; Thomas FP; Chao KR; Konersman CG; Cho MT; Brandt T; Straub V; Connolly AM; Schara U; Roos A; Tarnopolsky M; Höke A; Brown RH; Lee CH; Hornemann T; Dunn TM; Bönnemann CG
Nat Med; 2021 Jul; 27(7):1197-1204. PubMed ID: 34059824
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
Eichler FS; Hornemann T; McCampbell A; Kuljis D; Penno A; Vardeh D; Tamrazian E; Garofalo K; Lee HJ; Kini L; Selig M; Frosch M; Gable K; von Eckardstein A; Woolf CJ; Guan G; Harmon JM; Dunn TM; Brown RH
J Neurosci; 2009 Nov; 29(46):14646-51. PubMed ID: 19923297
[TBL] [Abstract][Full Text] [Related]
20. Substrate Availability of Mutant SPT Alters Neuronal Branching and Growth Cone Dynamics in Dorsal Root Ganglia.
Jun BK; Chandra A; Kuljis D; Schmidt BP; Eichler FS
J Neurosci; 2015 Oct; 35(40):13713-9. PubMed ID: 26446223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
